Edetic Acid

Edetic Acid

SCHEMBL333822

O.O.O.O.O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Cu+2].[Na+].[Na+]

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Edetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE known ✓ P12821 1/20 0.46
CHRM2 known ✓ P08172 1/20 0.43
ADRA2A known ✓ P08913 1/20 0.43
SLC6A2 known ✓ P23975 1/20 0.43
SLC6A4 known ✓ P31645 1/20 0.43
ADRA1A known ✓ P35348 1/20 0.43
DRD3 known ✓ P35462 1/20 0.43
SLC6A3 known ✓ Q01959 1/20 0.43
HDAC3 known ✓ O15379 1/20 0.32
HDAC1 known ✓ Q13547 1/20 0.32
HDAC2 known ✓ Q92769 1/20 0.32
HDAC8 known ✓ Q9BY41 1/20 0.32
KDM4E B2RXH2 2/20 0.70
ALOX15 P16050 2/20 0.70
MAPT P10636 1/20 0.70
SMN1; SMN2 Q16637 1/20 0.70
TDP1 Q9NUW8 2/20 0.46
EYA2 O00167 1/20 0.46
APP P05067 1/20 0.46
BLM P54132 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Edetic Acid SCHEMBL28905272 1.00 KDM4E (0.70) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL9540648 1.00 KDM4E (0.70) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL10607814 0.97 KDM4E (0.73) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL8470881 0.97 KDM4E (0.73) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL7071979 0.97 KDM4E (0.73) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL8374505 0.97 KDM4E (0.73) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL1714086 0.97 KDM4E (0.73) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL243998 0.97 KDM4E (0.73) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL978169 0.97 KDM4E (0.73) KDM4EALOX15MAPTSMN1; SMN2TDP1
Edetic Acid SCHEMBL991956 0.97 KDM4E (0.73) KDM4EALOX15MAPTSMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113429429-A Production method of benzimidazole-2-methyl carbamate-8-hydroxyquinoline copper 苏州华道生物药业股份有限公司 2021-09-24 CN claimed
US-8282801-B2 Methods for passivating a metal substrate and related coated metal substrates PPG INDUSTRIES OHIO, INC. (US) 2012-10-09 US claimed
US-7011697-B2 Electroless gold plating solution KANTO KAGAKU KABUSHIKI KAISHA (JP) 2006-03-14 US claimed
US-20050098061-A1 Electroless gold plating solution KANTO KAGAKU KABUSHIKI KAISHA (JP) 2005-05-12 US claimed
US-20260124642-A1 SYSTEMS AND METHODS FOR TREATING A SUBSTRATE PPG INDUSTRIES OHIO, INC. (US) 2026-05-07 US disclosed
EP-3497263-B1 SEALING COMPOSITION PRC DESOTO INT INC (US) 2026-01-14 EP disclosed
EP-4658831-A2 COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING A SUBSTRATE PPG Industries Ohio Inc. (US) 2025-12-10 EP disclosed
US-20240344230-A1 SYSTEMS AND METHOD FOR TREATING A SUBSTRATE PPG INDUSTRIES OHIO, INC. (US) 2024-10-17 US disclosed
US-12104272-B2 Treated substrates PRC-DESOTO INTERNATIONAL, INC. (US) 2024-10-01 US disclosed
EP-3504356-B1 ALKALINE COMPOSITION FOR TREATING METAL SUBSTARTES PPG IND OHIO INC (US) 2024-08-21 EP disclosed
WO-2024163724-A2 COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING A SUBSTRATE PPG INDUSTRIES OHIO, INC. (US) 2024-08-08 WO disclosed
US-20240167164-A1 SYSTEMS AND METHODS FOR TREATING A SUBSTRATE PPG INDUSTRIES OHIO, INC. (US) 2024-05-23 US disclosed
US-20090084682-A1 METHODS FOR COATING A METAL SUBSTRATE AND RELATED COATED METAL SUBSTRATES PPG INDUSTRIES OHIO, INC. (US) 2009-04-02 US disclosed
US-20090084471-A1 METHODS FOR TREATING A FERROUS METAL SUBSTRATE PPG INDUSTRIES OHIO, INC. (US) 2009-04-02 US disclosed
WO-2009020794-A2 PRETREATMENT COMPOSITIONS AND METHODS FOR COATING A METAL SUBSTRATE PPG INDUSTRIES OHIO, INC. (US) 2009-02-12 WO disclosed
US-20090032144-A1 PRETREATMENT COMPOSITIONS AND METHODS FOR COATING A METAL SUBSTRATE PPG INDUSTRIES OHIO, INC. 2009-02-05 US disclosed
WO-2008076684-A1 METHODS FOR COATING A METAL SUBSTRATE AND RELATED COATED SUBSTRATES PPG INDUSTRIES OHIO, INC. (US) 2008-06-26 WO disclosed
US-20080145678-A1 METHODS FOR COATING A METAL SUBSTRATE AND RELATED COATED SUBSTRATES PPG INDUSTRIES OHIO, INC. 2008-06-19 US disclosed
US-7011697-B2 Electroless gold plating solution KANTO KAGAKU KABUSHIKI KAISHA (JP) 2006-03-14 US disclosed
US-20050098061-A1 Electroless gold plating solution KANTO KAGAKU KABUSHIKI KAISHA (JP) 2005-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260124642-A1 SYSTEMS AND METHODS FOR TREATING A SUBSTRATE PLA2G12B, PLA2G2D, SOD1 ACE 2306/4885CHRM2 1897/4885ADRA2A 3461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.